What This Top Dividend Portfolio Is Holding Now: Royal Dutch Shell Plc, GlaxoSmithKline plc and HSBC Holdings plc

Royal Dutch Shell Plc (LON:RDSB), GlaxoSmithKline plc (LON:GSK) and HSBC Holdings plc (LON:HSBA) are the heavyweight holdings of Merchants Trust (LON:MRCH).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

HSBC

Merchants Trust (LSE: MRCH) is on track to deliver 31 straight years of dividend increases.  The prospective yield is 4.6% at a recent share price of 516p. Picking great dividend shares has helped Merchants outperform the FTSE All-Share Index over the past three, five and 10 years.

Let’s take a look at the trust’s current top three holdings: Royal Dutch Shell (LSE: RDSB), GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) and HSBC (LSE: HSBA).

Royal Dutch Shell

The shares of oil titan Royal Dutch Shell are trading close to a 52-week high, having put on a bit of a spurt since the company announced its annual results on 30 January.

New boss Ben van Beurden, said that after Shell’s heavy investment for growth in recent years, “2014 will be a year where we are changing emphasis, to improve our returns and cash flow performance”. The new focus is good news for shareholders’ dividends.

The board raised the 2013 payout (declared in US dollars) by 4.7%, and early indications suggest a rise of 4.4% for 2014. The consensus forecast for the sterling dividend is 114p, giving a prospective income of 4.8% at a recent share price of 2,365p — well ahead of the market average yield of 3.1%.

GlaxoSmithKline

Pharmaceuticals group GlaxoSmithKline (GSK) is another global giant currently offering a dividend yield well above the market average.

GSK reported core earnings-per-share (EPS) growth of 4% on turnover growth of 1% when announcing its annual results earlier this month. The board guided for accelerating growth in 2014, saying it expects turnover to rise by 2% and EPS by 4%-8%.

The company increased the 2013 dividend by 5.4%, and analysts are forecasting a 5.1% rise to 82p this year. That represents a prospective yield of 4.9% at a recent share price of 1,680p.

HSBC

Concerns about slowing growth in many emerging markets have weighed on companies with high exposure to these economies. The shares of HSBC (originally the Hong Kong and Shanghai Banking Company), with its big presence in Asia, are currently trading close to a 52-week low.

The company posted a 9% rise in profits for 2013 in results announced this week, but that fell a bit short of market expectations. However, chief executive Stuart Gulliver said three years of restructuring and cost-cutting had made the group “leaner and simpler … with strong potential for growth”. The board upped the dividend (declared in US dollars) by 8.9%, with the chief exec saying: “Strong capital generation continues to support our progressive dividend policy”.

HSBC has said it intends to maintain the first three quarterly dividends for this year at the same level as 2013. Even a de minimis increase in the final dividend, to maintain the progressive dividend policy, would see a $0.50 payout for the year — about 31p at current exchange rates, giving a prospective income of around 5% at a recent share price of 628p

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

> G A Chester does not own any shares mentioned in this article. The Motley Fool has recommended shares in GlaxoSmithKline.

More on Investing Articles

Investing Articles

What on earth’s going on with Apple stock?

Andrew Mackie assesses the potential long-term impact on Apple’s stock should it move its manufacturing base outside of China.

Read more »

Smiling white woman holding iPhone with Airpods in ear
Investing Articles

Here’s how much a 28-year-old investor could have on retirement by putting £80 a week into a SIPP

Starting younger can have advantages when building up a SIPP. Christopher Ruane runs a slide rule over what value £80…

Read more »

Investing Articles

3 ISA mistakes to avoid in a turbulent stock market

Christopher Ruane runs through a trio of potentially costly mistakes investors may make when managing their ISA as the stock…

Read more »

Investing Articles

£20k to invest? Here are 2 high-yield dividend shares to consider for an ISA!

Maxing out a Stocks and Shares ISA could deliver a huge four-figure income with well-chosen dividend shares, explains Royston Wild.

Read more »

Investing Articles

With Tesla stock down 50% in tariff panic, is it time to consider buying?

Tesla stock’s been one of the biggest investment casualties of the market slump this year. Is this a buying opportunity?

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

I’m taking the Warren Buffett approach to stock market turbulence as I aim to build wealth

Warren Buffett's lived through many bad markets -- and profited handsomely along the way. Our writer's applying some Buffett wisdom…

Read more »

Investing Articles

With a 7% yield, should investors consider buying this unloved oil stock for passive income?

Profits are under pressure and shareholders are unhappy. Roland Head asks if this FTSE heavyweight could be a bargain buy…

Read more »

Passive income text with pin graph chart on business table
Investing Articles

Here’s 5-stock ISA portfolio that could generate £1,000 per year in passive income

UK investors looking for passive income could do very well sticking to the FTSE 100 and the FTSE 250. And…

Read more »